Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Lustigman

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
Vaccine|May 17, 2018
The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4<sup>+</sup> T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathwaySonia Jain, Parakkal Jovvian George, Wanyan Deng, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2006
In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccinationVirginia L Tchakouté, Simon P Graham, Siv Aina Jensen, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Aluminum Hydroxide Induces Protective Immunity and Reduces Immune EnhancementWen-Hsiang Chen, Xinrong Tao, Anurodh Agrawal, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 23, 2005
Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animalsJeffrey Bethony, Alex Loukas, Michael Smout, et al.
Vaccine|October 11, 2020
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancementWen-Hsiang Chen, Xinrong Tao, Anurodh Shankar Agrawal, et al.
NPJ Vaccines|October 22, 2025
Vaccination against Onchocerca volvulus induces IgG-mediated protective immunity dependent on neutrophils and complementNathan M Ryan, Jessica A Hess, Mohini Nakhale, et al.
Parasitology Research|May 8, 2023
Survival of worm masses of Onchocerca ochengi in gerbils and hamsters: implications for the development of an in vivo macrofilaricide screening modelRene Bilingwe Ayiseh, Glory Enjong Mbah, Faustin Pascal Tsague Manfo, et al.
NPJ Vaccines|January 27, 2021
Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross miceNathan M Ryan, Jessica A Hess, Fernando Pardo-Manuel de Villena, et al.
Human Vaccines & Immunotherapeutics|December 21, 2013
Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidateWen-Hsiang Chen, Lanying Du, Shivali M Chag, et al.
Pathogens (Basel, Switzerland)|January 20, 2021
An Integrated Approach to Identify New Anti-Filarial Leads to Treat River Blindness, a Neglected Tropical DiseaseRahul Tyagi, Christina A Bulman, Fidelis Cho-Ngwa, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Vaccine|May 17, 2018
The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4<sup>+</sup> T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathwaySonia Jain, Parakkal Jovvian George, Wanyan Deng, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2006
In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccinationVirginia L Tchakouté, Simon P Graham, Siv Aina Jensen, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Aluminum Hydroxide Induces Protective Immunity and Reduces Immune EnhancementWen-Hsiang Chen, Xinrong Tao, Anurodh Agrawal, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 23, 2005
Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animalsJeffrey Bethony, Alex Loukas, Michael Smout, et al.
Vaccine|October 11, 2020
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancementWen-Hsiang Chen, Xinrong Tao, Anurodh Shankar Agrawal, et al.
NPJ Vaccines|October 22, 2025
Vaccination against Onchocerca volvulus induces IgG-mediated protective immunity dependent on neutrophils and complementNathan M Ryan, Jessica A Hess, Mohini Nakhale, et al.
Parasitology Research|May 8, 2023
Survival of worm masses of Onchocerca ochengi in gerbils and hamsters: implications for the development of an in vivo macrofilaricide screening modelRene Bilingwe Ayiseh, Glory Enjong Mbah, Faustin Pascal Tsague Manfo, et al.
NPJ Vaccines|January 27, 2021
Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross miceNathan M Ryan, Jessica A Hess, Fernando Pardo-Manuel de Villena, et al.
Human Vaccines & Immunotherapeutics|December 21, 2013
Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidateWen-Hsiang Chen, Lanying Du, Shivali M Chag, et al.
Pathogens (Basel, Switzerland)|January 20, 2021
An Integrated Approach to Identify New Anti-Filarial Leads to Treat River Blindness, a Neglected Tropical DiseaseRahul Tyagi, Christina A Bulman, Fidelis Cho-Ngwa, et al.
Pageof 14